Kezar Life Sciences, Inc. — Director's Dealing 2018

Jun 27, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Kezar Life Sciences, Inc. (KZR)
CIK: 0001645666
Period of Report: 2018-06-25

Reporting Person: Morningside Venture Investments Ltd (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-06-25	Common Stock	C	1051630	—	Acquired	1051630	Direct
2018-06-25	Common Stock	C	1007422	—	Acquired	2059052	Direct
2018-06-25	Common Stock	P	250000	$15.00	Acquired	2309052	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-25	Series A Convertible Preferred Stock	$	C	1051630	Disposed		Common Stock (1051630)	Direct
2018-06-25	Series B Convertible Preferred Stock	$	C	1007422	Disposed		Common Stock (1007422)	Direct

Footnotes

F1: Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering.

F2: Louise Mary Garbarino, Jill Marie Franklin, Peter Stuart Allenby Edwards and Raymond Long Sing Tang, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL.